Oncopeptides AB (publ) (STO:ONCO)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.930
-0.650 (-14.19%)
Jul 11, 2025, 2:59 PM CET
55.34%
Market Cap 1.03B
Revenue (ttm) 39.84M
Net Income (ttm) -277.57M
Shares Out 225.76M
EPS (ttm) -1.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,160,085
Average Volume 3,614,481
Open 4.680
Previous Close 4.580
Day's Range 3.830 - 4.855
52-Week Range 1.100 - 4.820
Beta -0.60
RSI 95.72
Earnings Date Aug 21, 2025

About Oncopeptides AB

Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is Pepaxti (melflufen), a drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. The company’s PDC platform designed with two components, peptide carrier and a cytotoxic payload which utilizes the altered metabolism of cancer cells to hydrolyze PDC into active hyd... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 80
Stock Exchange Nasdaq Stockholm
Ticker Symbol ONCO
Full Company Profile

Financial Performance

In 2024, Oncopeptides AB's revenue was 31.65 million, a decrease of -10.14% compared to the previous year's 35.22 million. Losses were -284.61 million, 14.2% more than in 2023.

Financial Statements

News

Oncopeptides AB (STU:OND) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Market ...

Oncopeptides AB (STU:OND) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Market Focus

8 months ago - GuruFocus

Q3 2024 Oncopeptides AB Earnings Call Transcript

Q3 2024 Oncopeptides AB Earnings Call Transcript

8 months ago - GuruFocus

Oncopeptides AB (OSTO:ONCO) Q2 2024 Earnings Call Transcript Highlights: Revenue Surge and ...

Oncopeptides AB (OSTO:ONCO) Q2 2024 Earnings Call Transcript Highlights: Revenue Surge and Strategic Market Expansions

11 months ago - GuruFocus

Q2 2024 Oncopeptides AB Earnings Call Transcript

Q2 2024 Oncopeptides AB Earnings Call Transcript

11 months ago - GuruFocus